G20 Trade Ministers reach Consensus against Weaponization of Food through Coercive Trade Actions (See 'Corp Brief') Robotics to become accelerating tool in Every Specialty of Medicine: MoS (See 'Corp Brief') NITI Aayog organises National Workshop on SDG Budgeting in Kolkata (See 'Corp Brief') IPR - Fraudulent mobile applications deceptively imitating Plaintiff's branding and falsely projecting themselves as official investment platforms, deserves to be taken down: HC (See 'Legal Desk') First Tigress in Buxa Tiger Reserve released under Tiger Reintroduction Programme (See 'Corp Brief') CBN destroys over 10.84 tonnes of seized narcotic drugs (See 'Corp Brief') CRIT and IIFT organise three-day Orientation Course on Trade Negotiations (See 'Corp Brief') APEDA Facilitates FPO-led Export of Frozen Food Products from Haryana to Canada (See 'Corp Brief') PMLA - Provisional attachment invalid where material at hand does not show how in absence of provisional attachment, the properties could be so disposed off so as to frustrate confiscation proceedings: SAFEMA Tribunal (See 'Legal Desk') Ministry of Mines virtually launches Auction of Two Offshore Mineral Blocks (See 'Corp Brief') IPR - Goodwill of partnership is partnership asset, and only partners have right to property of firm subject to contract: HC (See 'Legal Desk') BHASHINI showcases Multilingual AI Solutions at GatiSheel Jammu & Kashmir 2.0 (See 'Corp Brief') IPR - Cable operator's licence did not extend to hotel's commercial use, as definition of subscriber under Cable Television Networks (Regulation) Act prohibits further transmission to any other person: HC (See 'Legal Desk') Ministry of Labour & Employment expands 'Shram Samvad' outreach across industrial clusters (See 'Corp Brief') A&C - Orders where Courts of Record refrain from exercising contempt jurisdiction are not appealable under Section 19 of CC Act: HC (See 'Legal Desk') Reddy inaugurates E-Waste Collection Stall (See 'Corp Brief') IBC - Regulatory fee introduced by Insolvency and Bankruptcy Board of India with effect from Oct 01, 2022, is neither ultra vires IBC nor violative to Art 14 of Constitution: HC (See 'Legal Desk') An unsuccessful 'success fee' litigation (See CORP EINSICHT)

Print

NPPA monitors prices of scheduled & non-scheduled medicines

Published: Jul 30, 2024

By TIOLCorplaws News Service

NEW DELHI, JULY 30, 2024: AS per the provisions of Drugs (Prices Control) Order, 2013 (DPCO, 2013), formulations listed in Schedule-I of the DPCO are defined as scheduled formulation under section 2(1)(zb) of DPCO, 2013. Formulations not included in Schedule-I are defined under Para 2(1)(v) of DPCO, 2013 as non-scheduled formulation. Thus, both schedule and non-schedule drugs are covered under DPCO, 2013. 

As per the extant provisions of DPCO, 2013, the ceiling prices of scheduled medicines are revised annually on the basis of Wholesale Price Index (WPI) (all commodities) for preceding calendar year by National Pharmaceutical Pricing Authority (NPPA), on or before 1st April of every year and is notified by the Government on the 1st day of April every year. The details of price fixed by NPPA are available at NPPA's website i.e. nppaindia.nic.in.  In case of non-scheduled formulation (branded or generic), as per para 20 of DPCO, 2013, no manufacturers can increase Maximum Retail Price (MRP) by more than 10% of MRP during preceding 12 months.  The maximum permissible increase in prices, as per the provisions of DPCO, 2013 for scheduled and non-scheduled drugs may or may not be availed by their respective manufacturers based on commercial considerations and market dynamics.

Under the Drugs and Cosmetics Act, 1945 and Rules thereunder, manufacturers of drugs are required to comply with conditions of manufacturing licence and the requirements of Good Manufacturing Practices (GMP).  As per the Drugs Rules, 1945, the manufacturing, testing, labeling, packaging, storage and distribution are required to be carried out in compliance with the conditions of license including the Good manufacturing practices (GMP) prescribed under the Schedule M of the Drugs Rules, 1945. In case of violation, the Licensing Authority is empowered to take action as per the said Act and Rules.

NPPA monitors the prices of scheduled as well as non-scheduled medicines under DPCO, 2013.  Action is taken against companies, found selling formulations at prices higher than the permissible price, and the overcharged amount is recovered from the company as per the relevant provisions of the DPCO, 2013. During the financial year 2023-24, Rs. 72.73 crore was recovered from the defaulting companies.

This information was given by the Union Minister of State for Chemicals and Fertilizers Anupriya Patel in Rajya Sabha in reply to a question today.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.